国医大师李佃贵基于"浊毒"理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍
National Master of TCM Li Diangui's Experience in Differentiating and Treating Gastric Mucosal Barrier of Precancerous Lesions in Chronic Atrophic Gastritis Based on"Turbidity-toxin"Theory
张慧 1姜璐 2陈俊生 3张云松 2李佃贵
作者信息
- 1. 山东中医药大学,山东 济南 250014;济南市中医医院,山东 济南 250014
- 2. 山东中医药大学附属医院,山东 济南 250014
- 3. 山东中医药大学,山东 济南 250014
- 折叠
摘要
国医大师李佃贵以"浊毒"理论为指导,基于本病脾虚毒损胃络的病机特点,分别采用化浊解毒、补虚荣络、祛瘀通络的治法以改善或增强胃黏膜屏障功能,降低慢性萎缩性胃炎癌变率.
Abstract
Under the guidance of"turbidity toxin"theory,based on the pathogenesis of spleen deficiency and toxin damaged stomach collateral,national master of TCM Li Diangui adopted resolving turbidity and detoxifying,tonifying the deficiency and nourishing the collateral,removing stasis and dredging the collateral respectively to improve or enhance gastric mucosal barrier function and reduce the rate of carcinogenesis of chronic atrophic gastritis(CAG).
关键词
萎缩性胃炎/浊毒/癌前病变/胃黏膜屏障Key words
chronic atrophic gastritis/turbidity toxin/precancerous lesions/gastric mucosal barrier引用本文复制引用
基金项目
国家中医药管理局第六批全国老中医药专家学术经验继承项目(2018-2019)()
山东省中医药管理局齐鲁医派中医药特色技术推广项目()
出版年
2024
国家科技期刊平台
NSTL
万方数据